Treatment of Unresectable Stage IV Metastatic Melanoma With Aviscumine After Anti-Neoplastic Treatment Failure: A Phase II, Multi-Centre Study

Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/s40425-014-0027-z